Home > BIGG > Search result

    Results: 3

    Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology

    Baddini-Martinez, Jose; Ferreira, Juliana; Tanni, Suzana; Alves, Luis; Cabral Junior, Benedicto Francisco; Carvalho, Carlos Roberto Ribeiro; Cezare, Talita; Costa, Claudia da; Gazzana, Marcelo; Jezler, Sergio; Adib Kairalla, Ronaldo; Kawano-Dourado, Leticia; Lima, Mariana Silva; Mancuzo, Eliane; Moreira, Maria Auxiliadora Carmo; Rodrigues, Marcelo Palmeira; Rodrigues, Silvia Carla Sousa; Rubin, Adalberto Sperb; Lopes, Rogerio; Steidle, Leila John Marques; Storrer, Karin; Baldi, Bruno Guedes.
    J. bras. pneumol; 46 (2), 2020
    Idiopathic pulmonary fibrosis (IPF) is a form of chronic interstitial lung disease of unknown cause, which predominantly affects elderly men who are current or former smokers. Even though it is an uncommon disease, it is of great importance because of its severity and poor prognosis. In recent decades, s...
    Idiopathic Pulmonary Fibrosis/drug therapy, Idiopathic Pulmonary Fibrosis/diagnosis, Adrenal Cortex Hormones/therapeutic use, Acetylcysteine/therapeutic use, Endothelin Receptor Antagonists/therapeutic use, Phosphodiesterase 5 Inhibitors/therapeutic use, Critical Pathways/standards, Gastroesophageal Reflux/drug therapy
    Fulltext

    Gastro-oesophageal reflux disease in children and young people: diagnosis and management

    England. National Institute for Health and Care Excellence.
    This guideline covers diagnosing and managing gastro-oesophageal reflux disease in children and young people (under 18s). It aims to raise awareness of symptoms that need investigating and treating, and to reassure parents and carers that regurgitation is common in infants under 1 year....
    Gastroesophageal Reflux/diagnosis, Gastroesophageal Reflux/drug therapy, Proton Pump Inhibitors/therapeutic use, Histamine H2 Antagonists/therapeutic use, Endoscopy, Digestive System
    Fulltext

    Deprescribing proton pump inhibitors: evidence-based clinical practice guideline

    Farrell, B; Pottie, K; Thompson, W; Boghossian, T; Pizzola, L; Rashid, F. J; Rojas-Fernandez, C; Walsh, K; Welch, V; Moayyedi, P.
    Can. fam. physician; 63 (5), 2017
    OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper or stop proton pump inhibitors (PPIs); to focus on the highest level of evidence available and seek input from primary care professionals in the guideline development, review, and endors...
    Proton Pump Inhibitors/adverse effects, Gastroesophageal Reflux/drug therapy, Heartburn/drug therapy, Esophagitis/drug therapy, Proton Pump Inhibitors/administration & dosage, Deprescriptions, Clinical Decision-Making, Gastrointestinal Diseases/drug therapy
    Fulltext